P3 Study in Acne Comparing Once Daily SB204 and Vehicle

Summary

This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.

Timeline

Start

2016-02-22

Primary completion

2016-12

Completion

2016-12-21

Drugs

Indications